Walker 256 tumor growth suppression by crotoxin involves formyl peptide receptors and lipoxin a(4)
dc.contributor.author | Brigatte, Patricia | |
dc.contributor.author | Faiad, Odair Jorge | |
dc.contributor.author | Ferreira Nocelli, Roberta Cornelio | |
dc.contributor.author | Landgraf, Richardt G. [UNIFESP] | |
dc.contributor.author | Palma, Mario Sergio | |
dc.contributor.author | Cury, Yara | |
dc.contributor.author | Curi, Rui | |
dc.contributor.author | Sampaio, Sandra Coccuzzo | |
dc.date.accessioned | 2019-01-21T10:30:00Z | |
dc.date.available | 2019-01-21T10:30:00Z | |
dc.date.issued | 2016 | |
dc.description.abstract | We investigated the effects of Crotoxin (CTX), the main toxin of South American rattlesnake (Crotalus durissus terrificus) venom, on Walker 256 tumor growth, the pain symptoms associated (hyperalgesia and allodynia), and participation of endogenous lipoxin A(4). Treatment with CTX (s.c.), daily, for 5 days reduced tumor growth at the 5th day after injection of Walker 256 carcinoma cells into the plantar surface of adult rat hind paw. This observation was associated with inhibition of new blood vessel formation and decrease in blood vessel diameter. The treatment with CTX raised plasma concentrations of lipoxin A 4 and its natural analogue 15-epi-LXA(4) 4, an effect mediated by formyl peptide receptors (FPRs). In fact, the treatment with Boc-2, an inhibitor of FPRs, abolished the increase in plasma levels of these mediators triggered by CTX. The blockage of these receptors also abolished the inhibitory action of CTX on tumor growth and blood vessel formation and the decrease in blood vessel diameter. Together, the results herein presented demonstrate that CTX increases plasma concentrations of lipoxin A 4 and 15-epi-LXA 4, which might inhibit both tumor growth and formation of new vessels via FPRs. | en |
dc.description.affiliation | Special Laboratory of Pain and Signaling, Butantan Institute, Avenida Vital Brazil 1500, 05503-900 São Paulo, SP, Brazil | |
dc.description.affiliation | CEIS/Department of Biology, Institute of Biosciences of Rio Claro, São Paulo State University (UNESP), Rio Claro, SP, Brazil | |
dc.description.affiliation | Laboratory of Pathophysiology, Butantan Institute, Avenida Vital Brazil 1500, 05503-900 São Paulo, SP, Brazil | |
dc.description.affiliation | Department of Natural Sciences, Mathematics and Education, Agricultural Sciences Center, Federal University of São Carlos, Rodovia Anhanguera Km 174, 13600-970 Araras, SP, Brazil | |
dc.description.affiliation | Laboratory of Inflammation and Vascular Pharmacology, Federal University of São Paulo, Rua São Nicolau 210, 09913-030 Diadema, SP, Brazil | |
dc.description.affiliation | Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São Paulo, Avenida Professor Lineu Prestes 1524, 05508-900 São Paulo, SP, Brazil | |
dc.description.affiliation | Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Avenida Professor Lineu Prestes 1524, 05508-900 São Paulo, SP, Brazil | |
dc.description.affiliationUnifesp | Laboratory of Inflammation and Vascular Pharmacology, Federal University of São Paulo, Rua São Nicolau 210, 09913-030 Diadema, SP, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (fellowship-CAPES) | |
dc.description.sponsorship | PAP (fellowship-Secretaria da Saude do Estado de Sao Paulo) | |
dc.description.sponsorship | FAPESP [07/52447-8] | |
dc.description.sponsorship | Guggenheim Foundation | |
dc.description.sponsorshipID | FAPESP: 07/52447-8 | |
dc.identifier | http://dx.doi.org/10.1155/2016/2457532 | |
dc.identifier.citation | Mediators Of Inflammation. London, 2016. | |
dc.identifier.doi | 10.1155/2016/2457532 | |
dc.identifier.file | WOS000374851200001.pdf | |
dc.identifier.issn | 0962-9351 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/49524 | |
dc.identifier.wos | WOS:000374851200001 | |
dc.language.iso | eng | |
dc.publisher | Hindawi ltd | |
dc.relation.ispartof | Mediators Of Inflammation | |
dc.rights | Acesso aberto | |
dc.subject | Crotalus-Durissus-Terrificus | en |
dc.subject | Aspirin-Triggered Lipoxins | en |
dc.subject | Arachidonic-Acid | en |
dc.subject | Snake-Venom | en |
dc.subject | Antiangiogenic Therapy | en |
dc.subject | Cell-Proliferation | en |
dc.subject | Lipid Mediators | en |
dc.subject | Analog Suppress | en |
dc.subject | Cobra Venom | en |
dc.subject | Cancer Pain | en |
dc.title | Walker 256 tumor growth suppression by crotoxin involves formyl peptide receptors and lipoxin a(4) | en |
dc.type | Artigo |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- WOS000374851200001.pdf
- Tamanho:
- 7.96 MB
- Formato:
- Adobe Portable Document Format
- Descrição: